LRPPRC and SLIRP synergize to maintain sufficient and orderly mammalian mitochondrial translation.
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
In mammals, the leucine-rich pentatricopeptide repeat protein (LRPPRC) and the stem-loop interacting RNA-binding protein (SLIRP) form a complex in the mitochondrial matrix that is required throughout the life cycle of most mitochondrial mRNAs. Although pathogenic mutations in the LRPPRC and SLIRP genes cause devastating human mitochondrial diseases, the in vivo function of the corresponding proteins is incompletely understood. We show here that loss of SLIRP in mice causes a decrease of complex I levels whereas other OXPHOS complexes are unaffected. We generated knock-in mice to study the in vivo interdependency of SLIRP and LRPPRC by mutating specific amino acids necessary for protein complex formation. When protein complex formation is disrupted, LRPPRC is partially degraded and SLIRP disappears. Livers from Lrpprc knock-in mice had impaired mitochondrial translation except for a marked increase in the synthesis of ATP8. Furthermore, the introduction of a heteroplasmic pathogenic mtDNA mutation (m.C5024T of the tRNAAla gene) into Slirp knockout mice causes an additive effect on mitochondrial translation leading to embryonic lethality and reduced growth of mouse embryonic fibroblasts. To summarize, we report that the LRPPRC/SLIRP protein complex is critical for maintaining normal complex I levels and that it also coordinates mitochondrial translation in a tissue-specific manner.
Description
Acknowledgements: Sample preparation of immunoprecipitated samples and LC–MS/MS data acquisition was carried out by the Proteomics Biomedicum core facility at Karolinska Institutet. Mouse knock-in lines were generated by the Karolinska Genome Engineering and the Karolinska Center for Transgene Technologies core facilities of Karolinska Institutet. Recombinant protein expression and purification was performed by the Protein Science Facility (we would like to thank Henrik Spåhr, Emilia Strandback, and Henry Ampah-Korsah for assistance) at Karolinska Institutet, Sweden.
Funder: Max Planck Society; doi: https://doi.org/10.13039/501100004189
Journal Title
Conference Name
Journal ISSN
1362-4962
Volume Title
Publisher
Publisher DOI
Rights and licensing
Sponsorship
Swedish Cancer Foundation (21 1409 Pj)
Knut and Alice Wallenberg (2016.0050, 2019.0109)
Swedish Brain Foundation (FO2021-0080)
European Research Council (2016-741366)
Swedish Diabetes Foundation (DIA2020-516, DIA2021-620)
Novo Nordisk Foundation (NNF20OC006316, NNF22OC0078444)
Swedish government (county councils, SLL2018.0471, 20180417)

